Saber Imani

Key Laboratory Of Artificial Organs And Computational Medicine In Zhejiang Province
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy.

Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: January 03, 2026

Retraction Note: Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact.

Retraction Note: Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact.

Journal: NPJ vaccines

Published: November 14, 2025

Nanoparticle technologies in precision oncology and personalized vaccine development: Challenges and advances.

Nanoparticle technologies in precision oncology and personalized vaccine development: Challenges and advances.

Journal: International journal of pharmaceutics: X

Published: March 11, 2025

Neoantigen mRNA vaccines and A2A receptor antagonism: A strategy to enhance T cell immunity.

Neoantigen mRNA vaccines and A2A receptor antagonism: A strategy to enhance T cell immunity.

Journal: Human vaccines & immunotherapeutics

Published: January 30, 2025

Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy.

Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 16, 2025

The evolution of BRAF-targeted therapies in melanoma: overcoming hurdles and unleashing novel strategies.

The evolution of BRAF-targeted therapies in melanoma: overcoming hurdles and unleashing novel strategies.

Journal: Frontiers in oncology

Published: September 30, 2024

Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy.

Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy.

Journal: Frontiers in cellular and infection microbiology

Published: September 24, 2024

Exploration of drug repurposing for Mpox outbreaks targeting gene signatures and host-pathogen interactions.

Exploration of drug repurposing for Mpox outbreaks targeting gene signatures and host-pathogen interactions.

Journal: Scientific reports

Published: September 05, 2024

Current innovations in mRNA vaccines for targeting multidrug-resistant ESKAPE pathogens.

Current innovations in mRNA vaccines for targeting multidrug-resistant ESKAPE pathogens.

Journal: Biotechnology advances

Published: August 19, 2024

Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155.

Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155.

Journal: International journal of medical sciences

Published: August 09, 2024

Navigating ESKAPE Pathogens: Considerations and Caveats for Animal Infection Models Development.

Navigating ESKAPE Pathogens: Considerations and Caveats for Animal Infection Models Development.

Journal: ACS infectious diseases

Published: June 12, 2024

The p110α/ΔNp63α complex mutations in triple-negative breast cancer: Potential targets for transcriptional-based therapies.

The p110α/ΔNp63α complex mutations in triple-negative breast cancer: Potential targets for transcriptional-based therapies.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: November 19, 2023

Showing 1-12 of 75

Last Updated: 09/26/2026